Cargando…
Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration
BACKGROUND: This study aimed to understand the mechanism of action of deoxythymidylate kinase (DTYMK) and its effect on the prognosis of patients with pancreatic cancer. So as to provide better reference value for improving the clinical management of pancreatic cancer patients. METHODS: First, The C...
Autores principales: | Bao, Wenguang, Yang, Haiyan, Zhou, Shengsheng, Huang, Fengxiang, Wei, Zhe, Peng, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331742/ https://www.ncbi.nlm.nih.gov/pubmed/37435228 http://dx.doi.org/10.21037/jgo-23-393 |
Ejemplares similares
-
Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma
por: Zhang, Yue, et al.
Publicado: (2022) -
Deoxythymidylate Kinase as a Promising Marker for Predicting Prognosis and Immune Cell Infiltration of Pan-cancer
por: Lan, Tianfeng, et al.
Publicado: (2022) -
DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Guo, Yiwen, et al.
Publicado: (2021) -
DTYMK is essential for genome integrity and neuronal survival
por: Vanoevelen, Jo M., et al.
Publicado: (2021) -
The Impact of DTYMK as a Prognostic Marker in Colorectal Cancer
por: Aloliqi, Abdulaziz A., et al.
Publicado: (2023)